LoboVault Home
 

Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes

LoboVault

Please use this identifier to cite or link to this item: http://hdl.handle.net/1928/2372

Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes

Show full item record

Title: Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
Author: Nathan, DM; Cleary, PA; Backlund, JY; Genuth, SM; Lachin, JM; Orchard, TJ; Raskin, P; Zinman, B; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group
Subject(s): normoglycemia
microvascular
neurologic
type 1 diabetes
Abstract: BACKGROUND: Intensive diabetes therapy aimed at achieving near normoglycemia reduces the risk of microvascular and neurologic complications of type 1 diabetes. We studied whether the use of intensive therapy as compared with conventional therapy during the Diabetes Control and Complications Trial (DCCT) affected the long-term incidence of cardiovascular disease. METHODS: The DCCT randomly assigned 1441 patients with type 1 diabetes to intensive or conventional therapy, treating them for a mean of 6.5 years between 1983 and 1993. Ninety-three percent were subsequently followed until February 1, 2005, during the observational Epidemiology of Diabetes Interventions and Complications study. Cardiovascular disease (defined as nonfatal myocardial infarction, stroke, death from cardiovascular disease, confirmed angina, or the need for coronary-artery revascularization) was assessed with standardized measures and classified by an independent committee. RESULTS: During the mean 17 years of follow-up, 46 cardiovascular disease events occurred in 31 patients who had received intensive treatment in the DCCT, as compared with 98 events in 52 patients who had received conventional treatment. Intensive treatment reduced the risk of any cardiovascular disease event by 42 percent (95 percent confidence interval, 9 to 63 percent; P=0.02) and the risk of nonfatal myocardial infarction, stroke, or death from cardiovascular disease by 57 percent (95 percent confidence interval, 12 to 79 percent; P=0.02). The decrease in glycosylated hemoglobin values during the DCCT was significantly associated with most of the positive effects of intensive treatment on the risk of cardiovascular disease. Microalbuminuria and albuminuria were associated with a significant increase in the risk of cardiovascular disease, but differences between treatment groups remained significant (P< or =0.05) after adjusting for these factors. CONCLUSIONS: Intensive diabetes therapy has long-term beneficial effects on the risk of cardiovascular disease in patients with type 1 diabetes. Copyright 2005 Massachusetts Medical Society.
Date: 2005-12-22
Publisher: Nathan, D.M., The New England Journal of Medicine
Citation: Volume: 353 Issue: 25, p. 2643-53
Description: PubMed ID: 16371630
URI: http://hdl.handle.net/1928/2372
ISSN: 0028-4793

Files in this item

Files Size Format View
Nathan-16371630.pdf 794.9Kb PDF View/Open

This item appears in the following Collection(s)

Show full item record

UNM Libraries

Search LoboVault


Advanced Search

Browse

My Account